Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
National Seating & Mobility Gets New PE Investor
Cinven, the London-based private equity firm, struck a deal last week to acquire National Seating & Mobility (NMS) from Court Square Capital Partners. The sale, which was valued at $850 million by sources cited in PEHub Buyouts, resulted from a Harris Williams-run auction that began in August. Court Square Capital bought it from Wellspring Capital Management in 2016, but now Cinven will be backing the company. NMS provides complex rehab technology (CRT) solutions focusing on highly customized wheelchairs for patients diagnosed with long-term or permanent loss of mobility. NMS operates through Rehab Technician Specialist (RTS) which connects with physicians and physical therapists. The... Read More »
Healthcare Staffing Firms in Steady Demand
As healthcare companies and providers across the industry wrestle with staffing shortages and retention, staffing firms are looking to fill some of the gaps, thus driving M&A activity. According to our Deal Search Online database, there have been nine acquisitions focused on healthcare staffing firms so far this year, and that number will most likely grow. If a price had been disclosed, Medical Solutions’ takeover of C&A Industries, Inc. this month would surely be among the largest deals in this segment. Medical Solutions, a portfolio company of TPG Growth, specializes in placing registered nurses in temporary travel assignments throughout the country. The... Read More »
CROs and CDMOs are Still Selling Fast
This past week Permira, a global investment firm based in the United Kingdom, spent $2.4 billion for Cambrex Corporation (NYSE: CBM). Cambrex is a premier contract development and manufacturing organization (CDMO) in the small molecule space and provides drug substance, drug product and analytical services across the entire drug lifecycle. The $2.4 billion purchase price includes the company’s net debt, for 4.2x revenue and 16.3x EBITDA, represents a 47.1% premium to Cambrex’s closing price of $40.78 on August 6. The target reported a number of its own acquisitions recently, making the CDMO a more attractive buy. Cambrex acquired Halo Pharma in 2018 and Avista Pharma Solutions... Read More »
HCA Healthcare Buys Network of Urgent Care Centers in Texas
HCA Healthcare (NYSE: HCA) announced last week it purchased 24 MedSpring urgent care centers in Texas from Fresenius Medical Care (NYSE: FMS). MedSpring centers offer treatment for a wide range of common injuries and illnesses. The 24 clinics are dispersed throughout major cities like Austin, Dallas and Houston. Fresenius acquired MedSpring Urgent Care Centers in 2014 for an undisclosed price. At the time, the company operated 14 centers, so this most recent deal shows significant growth in the target company. HCA Healthcare now operates a total of 160 centers across the country. The MedSpring centers will be rebranded to CareNow Urgent Care and operated by HCA. This deal comes on the... Read More »
Healthcare Payment Firm Bought for $3.2 Billion
As the healthcare market evolves, so does the need to manage the payment flows between managed care companies, providers and patients. That rising demand surely played a role in UnitedHealth Group, Inc.’s (NYSE: UNH) acquisition of Equian LLC, an end-to-end healthcare payment firm. UnitedHealth paid approximately $3.2 billion, according to The Wall Street Journal, citing sources familiar with the matter. Equian manages over $500 billion in claims data annually through its platform, assisting clients by avoiding, identifying, pricing, analyzing clinical codes, and ultimately recovering inaccurate transactions in healthcare, workers compensation, and property and casualty markets. If... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
